Literature DB >> 7065556

Role of vasopressin in abnormal water excretion in cirrhotic patients.

D Bichet, V Szatalowicz, C Chaimovitz, R W Schrier.   

Abstract

Twelve stable cirrhotic patients with ascites received a 20 mL/kg water load. Seven patients had abnormal water excretion (27.3% +/- 5.4% of the water load in 5 hours) and a minimal urine osmolality of 262 mosmol/kg water. Five patients excreted 82.6% in 5 hours and had a minimal urine osmolality of 65 mosmol/kg water. Mean plasma arginine vasopressin values after water load were significantly higher in Group 1 (1.34 +/- 0.36 pg/mL) than in Group 2 (undetectable). An effective blood volume lower in Group 1 than Group 2 patients was suggested by a lower plasma albumin (2.5 versus 3.3 g/dL, p less than 0.02), a higher pulse rate (96 versus 72, p less than 0.001), a higher plasma renin activity (7.8 versus 1.5 ng/mL . h, p less than 0.005), a higher plasma aldosterone (66 versus 21 ng/dL, p less than 0.05), and a lower urinary sodium excretion (2.7 versus 14.2 meq Na/5 h, p less than 0.005). The results suggest that nonosmotic stimulation of vasopressin secondary to a decrease in effective blood volume is an important factor in the abnormal water excretion of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065556     DOI: 10.7326/0003-4819-96-4-413

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  41 in total

Review 1.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 2.  Water retention and aquaporins in heart failure, liver disease and pregnancy.

Authors:  R W Schrier; M A Cadnapaphornchai; M Ohara
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

3.  Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.

Authors:  D Sacerdoti; M Balazy; P Angeli; A Gatta; J C McGiff
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 4.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

5.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

6.  Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis.

Authors:  G Decaux; P Cauchie; A Soupart; M Kruger; F Delwiche
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

Review 7.  Pathogenesis of ascites and hepatorenal syndrome.

Authors:  S P Wilkinson; K P Moore; V Arroyo
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.

Authors:  R B Vaughan; P W Angus; J P F Chin-Dusting
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Clinical settings and vasopressin function in hyponatraemic children.

Authors:  M Gerigk; M Bald; F Feth; W Rascher
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

10.  Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.

Authors:  Hiroyuki Nakanishi; Masayuki Kurosaki; Takanori Hosokawa; Yuka Takahashi; Jun Itakura; Shoko Suzuki; Yutaka Yasui; Nobuharu Tamaki; Natsuko Nakakuki; Hitomi Takada; Mayu Higuchi; Yasuyuki Komiyama; Tsubasa Yoshida; Kenta Takaura; Tsuguru Hayashi; Konomi Kuwabara; Sei Sasaki; Namiki Izumi
Journal:  J Gastroenterol       Date:  2015-11-26       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.